Exchange: NASDAQ·Updated 04:10 PM EST

COAG News

News
all
press releases
Hemab Therapeutics Holdings, Inc. (NASDAQ:COAG - Get Free Report) has been assigned an average recommendation of "Moderate Buy" from the ten research firms that are currently covering the firm, MarketBeat Ratings reports. One equities research analyst has rated the stock with a sell rating, one has...
MarketBeat
The Galien Foundation Announces 2026 Prix Galien USA Nominees for "Best Digital Health Solution," "Best Medical Technology," "Incubators, Accelerators and Equity," and "Best Startup" The Galien Foundation Announces 2026 Prix Galien USA Nominees for "Best Digital Health Solution," "Best Medical...
PR Newswire

Advertisement|Remove ads.